Related Experiment Video
Updated: May 4, 2026
Biological Compatibility Profile on Biomaterials for Bone Regeneration
Published on: November 16, 2018
Biological response to β-tricalcium phosphate/calcium sulfate synthetic graft material: an experimental study
Minas D Leventis1, Peter Fairbairn, Ismene Dontas
1*Clinical Assistant, Department of Oral and Maxillofacial Surgery, Dental School, University of Athens, Greece. †Visiting Professor, Department of Periodontology and Implant Dentistry, School of Dentistry, University of Detroit Mercy, Detroit, MI. ‡Professor of Experimental Surgical Research, School of Medicine, University of Athens, Athens, Greece. §Maxillofacial Surgeon, Department of Maxillofacial Surgery, Greek Anticancer Institute, St Savvas Hospital, Athens, Greece. ‖Professor, Department of Oral Surgery, University of Naples Federico II, Naples, Italy. ¶Pathologist, Laboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, University of Athens, Athens, Greece. #Associate Professor, Department of Oral and Maxillofacial Surgery, Dental School, University of Athens, Athens, Greece.
Purpose:
The aim of this study was to evaluate the effect of a biphasic synthetic bone graft material composed of β-tricalcium phosphate (β-TCP) and calcium sulfate (CS) in 12 New Zealand rabbits.
Materials And Methods:
A circular bicortical critical-size cranial defect was created in each of 12 rabbits. The defects were grafted with β-TCP/CS. Animals were euthanized at 3 and 6 weeks. Harvested tissue specimens were evaluated histologically and histomorphometrically. Parameters associated with new bone formation and graft resorption were measured and calculated. The results were statistically analyzed using the Mann-Whitney test.
Results:
Our data demonstrated the biocompatibility of synthetic β-TCP/CS, as no inflammatory response was observed, and no fibrosis was developed between the graft particles and the newly formed bone. Moreover, β-TCP/CS acted as an osteoconductive scaffold that allowed a significant bone regeneration and graft biodegradation with time.
Conclusion:
In this animal model, synthetic β-TCP/CS proved to be a biocompatible, osteoconductive, and bioresorbable bone graft substitute.
